# Mesa Laboratories Inc: Form 10-Q/A for the period ended Jun 30, 2012

- Company: [Mesa Laboratories Inc](/companies/mlab.md) (CIK 724004)
- Form: 10-Q/A
- Filed: 2012-09-17
- Accepted by EDGAR: Sep 17, 2012, 10:40 ET
- Period: 2012-06-30
- Accession: 0001104659-12-063667
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/724004/000110465912063667/a12-21348_110qa.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/724004/000110465912063667/

## Controls and procedures

As filed, 4,072 characters.

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) that are designed to reasonably ensure that information required to be disclosed by us in the reports we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Our management evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of June 30, 2012. Based on that evaluation, our management concluded that our disclosure controls and procedures were effective at June 30, 2012.

Our management, including our Chief Executive Officer and Chief Financial Officer, is responsible for establishing and maintaining adequate internal control over financial reporting as required by Sarbanes-Oxley (SOX) Section 404(a). Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with generally accepted accounting principles in the United States. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance of achieving their control objectives. Management evaluated the effectiveness of our internal control over financial reporting based on the framework in “Internal Control — Integrated Framework” issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).

Our management evaluated, with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our internal control over financial reporting as of June 30, 2012. Based on that evaluation, our management concluded that our internal control over financial reporting was effective at June 30, 2012. As allowed, this evaluation excludes the operations of Bios due to the recency of the acquisition. Revenues related to the Bios Acquisition were approximately 7% of total revenues for the quarter ended June 30, 2012.

### Changes in Internal Control Over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the quarter ended June 30, 2012, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

### SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

|  |  |  |  |
| --- | --- | --- | --- |
| MESA LABORATORIES, INC. |  |  |  |
| (Registrant) |  |  |  |
| DATED: | September 17, 2012 | BY: | /s/ John J. Sullivan, Ph.D. |
|  |  |  | John J. Sullivan, Ph.D. |
|  |  |  | Chief Executive Officer, |
|  |  |  | President, Treasurer, and Director |
| DATED: | September 17, 2012 | BY: | /s/ Steven W. Peterson |
|  |  |  | Steven W. Peterson |
|  |  |  | Vice President-Finance, |
|  |  |  | Chief Financial and Accounting Officer and Secretary |

3

Exhibits:

|  |  |
| ---: | --- |
| 31.1 | Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| 31.2 | Certification of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 |
| 32.1 | Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
| 32.2 | Certification of Chief Financial Officer Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |

4

Filed Sep 17, 2012.
Source: SEC EDGAR, the filing index for accession 0001104659-12-063667. Last ingested by Listed: Nov 13, 2026, 07:45 ET. No prices; not investment advice.
